Deborah Bauer, n/a

Director Biostatistics
Sanofi

Poster(s):

• (235) Dupilumab improves signs and symptoms of Chronic Spontaneous Urticaria regardless of baseline body mass index
  Wednesday, October 29, 2025

• (239) Dupilumab efficacy in patients with Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation with and without Emphysema
  Wednesday, October 29, 2025